Treatment with Sulodexide Downregulates Biomarkers for Endothelial Dysfunction in Convalescent COVID...
Treatment with Sulodexide Downregulates Biomarkers for Endothelial Dysfunction in Convalescent COVID-19 Patients
About this item
Full title
Author / Creator
Publisher
United States: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
United States: SAGE Publications
Subjects
More information
Scope and Contents
Contents
Persistent elevation of biomarkers associated with endothelial dysfunction in convalescent COVID-19 patients has been linked to an increased risk of long-term cardiovascular complications, including long COVID syndrome. Sulodexide, known for its vascular endothelial affinity, has demonstrated pleiotropic protective properties. This study aims to ev...
Alternative Titles
Full title
Treatment with Sulodexide Downregulates Biomarkers for Endothelial Dysfunction in Convalescent COVID-19 Patients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_ce511193a3644477a40c03fbf659642d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ce511193a3644477a40c03fbf659642d
Other Identifiers
ISSN
1076-0296,1938-2723
E-ISSN
1938-2723
DOI
10.1177/10760296241297647
